Artificial Intelligence
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%.
Today's issue
Refine Search
Latest Artificial Intelligence News & Features
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) acr 17 June 2024
Biotechnology
Ochre Bio and GSK ink liver disease collaboration 13 June 2024
Biotechnology
Vilya, a biotechnology company focused on designing novel medicines, has announced a $71 million expansion of its series A financing. 5 June 2024
Biotechnology
Biolojic Design inks multi-target drug collaboration with Merck 4 June 2024
Pharmaceutical
Privately-held company GAIA has had more than a front-row seat to observe the arrival of digital therapeutics and applications of AI in pharma over the past qua 4 June 2024
Biotechnology
AI-driven precision medicine company Exscientia has announced a headcount reduction of between 20% and 25%. 22 May 2024
Pharmaceutical
The use of AI across all industries and sectors has been heralded as driving efficiency and accelerating innovation, with some experts even citing the technolog 21 May 2024
Biotechnology
Nabla Bio bags $26M Series A financing and deals with three pharma majors 20 May 2024
Pharmaceutical
Boston, USA-based start-up Monte Rosa Therapeutics intends to raise around $100 million through a public share offering. 17 May 2024
Biotechnology
A new life science-based fund from NewVale Capital, an American equity firm, has raised $167 million for its debut fund. 14 May 2024
Biotechnology
At a cool $1 billion, the venture round secured by AI group Xaira ranks as the second-biggest raise in biotech history. In the drug discovery space, this financ 14 May 2024
Pharmaceutical
Advancing pharmaceutical processes with AI: The FDA's perspective 10 May 2024
Biotechnology
mRNA specialist Moderna has shared details of a year old collaboration with artificial intelligence leader OpenAI. 8 May 2024
Pharmaceutical
Pfizer names new chief strategy and innovation officer 7 May 2024
article
The UK’s medicines regulator has set out its strategic approach to artificial intelligence (AI). 3 May 2024
Pharmaceutical
The world’s top 20 pharma companies spent $145 billion between them on R&D investments in 2022-23—compared to the prior year’s $139 million—according to researc 29 April 2024
Biotechnology
In San Francisco, a new company focused on using artificial intelligence to power drug discovery has launched with more than $1 billion of committed capital. 24 April 2024
Biotechnology
Caris Life Sciences partners with Merck KGaA on ADCs 5 April 2024
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze